lobbying_activities: 3010119

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3010119	5bc5f833-153d-4df6-b78c-1c1516c64705	Q2	BIOCOM	400552652	BIOCOM	2023	second_quarter	CPT	Advocated for the protection of Intellectual Property rights Advocated for the protection of the Bayh-Dole Act and against using march-in provisions to control drug pricing Expressed opposition to the proposals waiving IP protections for covid-19 vaccines, diagnostics, and treatments under the TRIPS agreement. Expressed opposition to FDA and PTO collaboration activities that would undermine IP rights.	HOUSE OF REPRESENTATIVES,SENATE		75000	0	0	2023-07-18T12:54:39-04:00